Myopia, or nearsightedness, is a common eye condition. More than 40% of Americans can't see clearly at a distance because their eye is longer than normal. Usually myopia doesn't cause any problems ...

A UK trial finds that low-dose atropine modestly slows childhood myopia progression and axial eye growth over 2 years without ...

An eye drop a day could keep myopia at bay — at least temporarily. Using nightly eye drops with 0.05 percent atropine, a medication that relaxes the eye muscle responsible for focusing vision, may ...

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each ...

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

Drops commonly used to dilate pupils before eye exams could stave off nearsightedness in children, researchers said. Using low-concentration atropine eye drops in children could delay the onset of ...

SHERMAN OAKS, CA, UNITED STATES, March 9, 2026 /EINPresswire.com/ — As screen use, reading, and other near-vision demands remain part of daily life for many ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

A local optometrist explains how undetected vision problems can impact learning, behavior and long-term eye health.

Childhood myopia (short-sightedness) is becoming one of the fastest-growing public health challenges worldwide. Research by the Brien Holden Vision Institute estimates that nearly half of the world's ...

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each ...